Sign in
4

Changes in Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-26-044887

See Remarks sold 1,218 shares at $17.99 ($21,912)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bispham Barbara Harlin See Remarks 2026-06-22 Sale 10b5-1 −1,218 $17.99 $21,912 19,330 D
Open-market sales · 1,218 sh · avg $17.99 · $21,912
Loading xslF345X06/wk-form4_1782245005.xml…